1-4 of 4
IL-Young Kweon
Close
Sort by
Journal Articles

Imatinib Long Term Effects (ILTE) Study: An International Study to Evaluate Long-Term Effects in CML Patients.

Dong-Wook Kim, Laura Antolini, PhD, François-Xavier Mahon, MD, Francois Guilhot, MD, Michael Deininger, MD, PhD, Giuseppe Saglio, MD, Arnon Nagler, MD, Alessandro Rambaldi, MD, Enrica Morra, MD, Elisabetta Abruzzese, MD, Francesco Di Raimondo, M.D., Philipp le Coutre, MD, Rafael Hurtado Monroy, MD, Muheez A Durosinmi, MD, Onno Leeksma, MD, DPhil, Fabrizio Pane, MD, Stefania Miglietta, Il-Young Kweon, Josy Reiffers, MD, Maria Grazia Valsecchi, PhD, Carlo Gambacorti-Passerini, MD
Journal: Blood
Blood (2009) 114 (22): 2199.
https://doi.org/10.1182/blood.V114.22.2199.2199
Published: 2009
Journal Articles

Pleural Effusion in Dasatinib-Treated Chronic Myeloid Leukemia Patients after Imatinib Failure

Dongho Kim, PhD, Il-Young Kweon, Sa-Hee Park, Ji-Sun Lim, Hey-Sun Chung, Ha-Na Kim, Harriet Goh, Soo-Hyun Kim, Jung Lee, Won- Seok Kim, PhD, Dong-Wook Kim, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 4270.
https://doi.org/10.1182/blood.V112.11.4270.4270
Published: 2008
Journal Articles

Imatinib Long Term Effects (ILTE) Study: An Independent, International Study in CML Patients.

Carlo Gambacorti-Passerini, Dong-Wook Kim, François-Xavier Mahon, Giuseppe Saglio, Fabrizio Pane, François Guilhot, Michael W.N. Deininger, Arnon Nagler, Alessandro Rambaldi, Enrica Morra, Laura Antolini, IL-Young Kweon, Josy Reiffers, Lucia Tornaghi, Maria Grazia Valsecchi
Journal: Blood
Blood (2008) 112 (11): 1099.
https://doi.org/10.1182/blood.V112.11.1099.1099
Published: 2008
Journal Articles

Clinical Characteristics and Outcome of 20 Imatinib Mesylate Resistant Patients with T315I BCR-ABL Mutation.

Wan-Seok Kim, PhD, Il-Young Kweon, Soo Hyun Kim, Hyun Gyung Goh, Jeong Lee, Se Eun Jung, Dongho Kim, PhD, Sa-Hee Park, Ji-Sun Lim, Ha-Na Kim, Dong-Wook Kim, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 1954.
https://doi.org/10.1182/blood.V110.11.1954.1954
Published: 2007